Natalie L. Silver, MD MS

Assistant Professor
Division of Head and Neck Oncologic Surgery

 

Contact

ENT Clinic at Shands at UF

  • Phone: (352) 265-8989
  • Fax: (352) 265-8968

ENT Call Center
Patient Appointments

  • Phone: (352) 265-0920
  • Fax: (352) 627-4411

Academic Office

  • Phone: (352) 273-5199
  • Fax: (352) 392-6781

Email


Education

  • FELLOWSHIP, Head and Neck Surgery
    MD Anderson Cancer Center
    Houston, TX
    2014 – 2016
  • RESIDENCY, Otolaryngology
    University of Kentucky
    Lexington, KY
    2009 – 2014
  • MEDICAL SCHOOL, Doctor of Medicine (MD)
    Georgetown University School of Medicine
    Washington, DC
    2004 – 2009
  • GRADUATE, Masters of Science (MS)
    Georgtown University Graduate School of Arts and Sciences
    Washington, DC
    2002 – 2004
  • UNDERGRADUATE, Bachelor of Science (BS)
    Georgtown University College of Arts and Sciences
    Washington, DC
    1996 – 2000

Licensure

  • Florida Medical License (2016 – Present)
  • Texas Medical License (2015 – Present)

Certification

  • Board Certified, American Board of Otolaryngology Head and Neck Surgery (2015 – Present)

Academic Affiliations

  • American Academy of Otolaryngology-Head and Neck Surgery
  • American Head and Neck Society
  • American Rhinologic Society
  • Kentucky Society of Otolaryngology
  • Kentucky Medical Association

Publications

  1. Silver N, Weber R. Chapter 12. Surgery for Malignant Submandibular Gland Neoplsams. In Eisele and Bradley (ed.), Advances of Oto-Rhino-Laryngology. Karger. Undergoing Revisions, Anticipated Publication 2016.
  2. Tanaka N, Patel A, Wang J , Frederick M, Zhao M, Fitzgerald A, Xie T, Silver N, Caulin C, Zhou G, Skinner H , Johnson F, Myers J, Osman A. Wee-1 kinase inhibition sensitizes high risk HPV+ HNSCC to apoptosis through downregulation of MCl-1 and XIAP antiapoptotic proteins. Clinical Cancer Research, [Epub Ahead of Print] June 2015.
  3. Silver N, Arnold S, Gleason J, Kudrimoti M, Brill Y, Van Metre E, Valentino J. p16INK4a Status and Response to Induction Low Dose Fractionated Radiation in Head and Neck Cancer. Annals of Otology Rhinology and Laryngology, [Epub Ahead of Print] May 2015.
  4. Silver N, Sokoya F, Brill Y, Gal TJ. Laryngeal Blastomycosis. ENT Journal, Laryngology Clinics. Accepted 2014.
  5. Silver N, TJ Gal. Endoscopic CO2 Laser Management of Chemoradiation Related Cricopharyngeal Stenosis. Annals of Otology Rhinology and Laryngology. 2014;123(4):252-6.
  6. Gal TJ, Silver N. Chapter 116. Transoral Laser Resection of the Larynx. In Kountakis (ed.), Encyclopedia of Otolaryngology, Head and Neck Surgery. Springer-Verlag Berlin Heidelberg, 2013.
  7. Gal TJ, Silver N, Huang B. Demographics and treatment trends in sinonasal mucosal melanoma. Laryngoscope. 2011;121(9):2026-33.
  8. Ju JH, Maeng JS, Zemedkun M, Ahronovitz N (maiden name), Mack JW, Ferretti JA, Gelmann EP, Gruschus JM. Physical and functional interactions between the prostate suppressor homeoprotein NKX3.1 and serum response factor. Journal of Molecular Biology. 2006;360:989-99.
  9. Gelmann EP, Steadman DJ, Ma J, Ahronovitz N (maiden name), Voeller HJ, Swope S, Abbaszadegan M, Brown KM, Strand K, Hayes RB, Stampfer MJ. Occurrence of NKX3.1 C154T polymorphism in men with and without prostate cancer and studies of its effect on protein function. Cancer Research. 2002;62:2654-9.

Presentations

  • Silver N, Osman A, Patel A, Wang J, Tanaka N, Frederick M, Johnson F, Fu S, Myers J. A Regimen Combining the Wee1 Inhibitor AZD 1775, with the HDAC Inhibitor Vorinostat, is Highly Active Against Head and Neck Squamous Cell Carcinoma Harboring p53 Mutations. Oral Presentation. American Head and Neck Society Translational Science Meeting, Session: Breakthroughs – Paradigm Changes, New Thoughts, HNSCC & HPV. Boston, MA. April, 2015.
  • Silver N, Baffi J, Brill Y, Gal TJ, Albuquerque R, Ambati J, Valentino J.
  • Soluble VEGFR-2 Expression in Head and Neck Malignant Tumors. Poster Presentation. American Academy of Otolaryngology-Head and Neck Surgery annual meeting. Washington, DC. September, 2012.
  • Silver N, Arnold S, Gleason J, Kudrimoti M, Brill Y, Gal TJ, Van Metre E, Valentino J. p16 Status and Response to Low Dose Fractionated Radiation as a Chemopotentiator of Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Oral Presentation. AHNS 8th International Conference on Head and Neck Cancer. Toronto, Ontario. July, 2012.
  • Silver N, Arnold S, Gleason J, Kudrimoti M, Brill Y, Gal TJ, Van Metre E, Valentino J. p16 Status and Response to Low Dose Fractionated Radiation as a Chemopotentiator of Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Oral Presentation. Kentucky Society of Otolaryngology annual meeting. Louisville, Kentucky. March, 2012.
  • Silver N, TJ Gal Endoscopic CO2 Laser Management of Chemoradiation Related Cricopharyngeal Stenosis. Oral Presentation. Kentucky Society of Otolaryngology annual meeting. Lexington, Kentucky. March, 2011.
  • Gal TJ, Silver N, Endoscopic CO2 Laser Management of Chemoradiation Related Cricopharyngeal Stenosis. Poster Presentation. American Academy of Otolaryngology-Head and Neck Surgery annual meeting. Boston, Massachusetts. September, 2010.
  • Silver N, Tassler A, Malekzadeh S, Harley E. Balloon Dilation for Treatment of Recurrent Choanal Atresia. Poster Presentation. American Academy of Otolaryngology-Head and Neck Surgery annual meeting. Chicago, Illinois. September, 2008.
  • Ahronovitz N (maiden name), Cai B, Tuan J, Gelmann EP. Characterizing Transcriptional Activity of the Prostate Specific Homeoprotein, NKX3.1. Poster Presentation. 5th Annual Lombardi Cancer Center Research Fair and 17th Annual Student Research Days Competition and Exposition. Washington, DC. March, 2004.